Mixtard human 70/30 and Victim of child abuse - a phase IV clinical study of FDA data
No or too few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or too few reports are found.
What is Mixtard Human 70/30?
Mixtard human 70/30 has active ingredients of insulin recombinant purified human; insulin susp isophane semisynthetic purified human. It is used in type 1 diabetes. Currently, eHealthMe is studying from 1,105 Mixtard human 70/30 users.
What is Victim Of Child Abuse?
Victim of child abuse is found to be associated with 95 drugs and 23 conditions by eHealthMe. Currently, we are studying 260 people who have Victim of child abuse.
Do you take Mixtard human 70/30 and have Victim of child abuse?Check whether Victim of child abuse is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Mixtard human 70/30 side effects by duration, gender and age:
- Mixtard human 70/30 side effects (1,105 reports)
Victim of child abuse treatments and more:
- Victim of child abuse (260 reports)
All the drugs that are associated with Victim of child abuse:
All the conditions that are associated with Victim of child abuse:
How the study uses the data?
The study uses data from the FDA. It is based on insulin recombinant purified human; insulin susp isophane semisynthetic purified human (the active ingredients of Mixtard human 70/30) and Mixtard human 70/30 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Duodenal Ulcer Haemorrhage and pfizer biontech covid vaccine - now
- Caduet and Augmentin '125' drug interaction - a second ago
- Talacen and Pain - 2 seconds ago
- Hiatal Hernia and drugs of ingredients of anagrelide hydrochloride - 2 seconds ago
- Tranexamic Acid and Nabumetone drug interaction - 2 seconds ago
- Fluoxetine Hydrochloride and Octreotide Acetate drug interaction - 3 seconds ago
- Valturna and Penicillin drug interaction - 4 seconds ago
- Hectorol and Demadex drug interaction - 4 seconds ago
- Esidrix and Desyrel drug interaction - 4 seconds ago
- Peridex and Arestin drug interaction - 12 seconds ago